PreprintCited by 77Parkinson's Disease Mechanisms and TreatmentsAutophagy in Disease and TherapyMitochondrial Function and Pathology

TOM20 Gates PINK1 Activity And Mediates Its Tethering Of The TOM And TIM23 Translocases Upon Mitochondrial Stress

Open access

Preprint — published as 10.1073/pnas.2313540121

Abstract

Mutations in PTEN-induced putative kinase 1 (PINK1) cause autosomal recessive early onset Parkinson disease (PD). PINK1 is a Ser/Thr kinase that regulates mitochondrial quality control by triggering mitophagy mediated by the ubiquitin ligase Parkin. Upon mitochondrial damage, PINK1 accumulates on the outer mitochondrial membrane (OMM) forming a high molecular weight complex with the translocase of the outer membrane (TOM). PINK1 then phosphorylates ubiquitin, which enables recruitment and activation of Parkin followed by autophagic clearance of the damaged mitochondrion. Thus, Parkin-dependent mitophagy hinges on the stable accumulation of PINK1 on the TOM complex. Yet, the mechanism linking mitochondrial stressors to PINK1 accumulation and whether the translocases of the inner membrane (TIMs) are also involved, remain unclear. Herein, we demonstrate that mitochondrial stress induces the formation of a PINK1-TOM-TIM23 supercomplex in human cultured cell lines, dopamine neurons, and midbrain organoids. Moreover, we show that PINK1 is required to stably tether the TOM to TIM23 complexes in response to stress, such that the supercomplex fails to accumulate in cells lacking PINK1. This tethering is dependent on an interaction between the PINK1 NT-CTE module and the cytosolic domain of the Tom20 subunit of the TOM complex, the disruption of which, by either designer or PD-associated PINK1 mutations, inhibits downstream mitophagy. Together, the findings provide key insight into how PINK1 interfaces with the mitochondrial import machinery, with important implications for the mechanisms of mitochondrial quality control and PD pathogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2023.08.07.552252

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 80

  1. 2019, Parkinson’s Disease, Med. Clin. North Am, 103, 337, 10.1016/j.mcna.2018.10.014 · DOI
  2. 10.1016/j.neuron.2014.12.007 · DOI · Paper page
  3. 10.1146/annurev-genom-082410-101440 · DOI
  4. 2022, Mitochondrial quality control in health and in Parkinson’s disease, Physiol. Rev, 102, 1721, 10.1152/physrev.00041.2021 · DOI
  5. 2018, Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance, Curr. Biol. CB, 28, R170, 10.1016/j.cub.2018.01.004 · DOI · Paper page
  6. 10.1016/j.cmet.2014.01.010 · DOI
  7. 10.1038/nature14951 · DOI
  8. 10.1038/nature14859 · DOI
  9. 10.1038/s41556-019-0294-5 · DOI
  10. 10.1126/science.aan4146 · DOI
  11. 10.1038/s41586-019-1227-y · DOI
  12. 10.1126/science.1096284 · DOI · Paper page
  13. 10.1038/33416 · DOI · Paper page
  14. 10.1083/jcb.200910140 · DOI · Paper page
  15. 10.1371/journal.pgen.1004861 · DOI
  16. 10.1083/jcb.200809125 · DOI · Paper page
  17. 10.1038/nature13392 · DOI · Paper page
  18. 10.1016/j.devcel.2011.12.014 · DOI · Paper page
  19. 10.1074/jbc.M113.509653 · DOI
  20. 10.1083/jcb.201402104 · DOI · Paper page
  21. 10.1186/s12915-017-0470-7 · DOI
  22. 2019, Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond, Cell. Mol. Life Sci. CMLS, 76, 4589, 10.1007/s00018-019-03203-4 · DOI
  23. 10.1083/jcb.201007013 · DOI · Paper page
  24. 10.1038/ncb2012 · DOI · Paper page
  25. 10.1093/hmg/ddr048 · DOI · Paper page
  26. 10.1111/j.1471-4159.2011.07318.x · DOI · Paper page
  27. 10.15252/embj.201488104 · DOI · Paper page
  28. 10.1038/nature24645 · DOI
  29. 10.1016/j.neuron.2022.01.035 · DOI · Paper page
  30. 10.1038/embor.2012.14 · DOI · Paper page
  31. 10.1083/jcb.201008084 · DOI · Paper page
  32. 10.1016/j.molcel.2019.01.002 · DOI
  33. 10.4161/auto.24633 · DOI
  34. 10.1186/s13024-017-0174-z · DOI
  35. 10.1371/journal.pbio.1000298 · DOI · Paper page
  36. 10.1038/nature12748 · DOI · Paper page
  37. 2022, Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex, Mol. Cell, 82, 44, 10.1016/j.molcel.2021.11.012 · DOI
  38. 2022, Mapping of a N-terminal α-helix domain required for human PINK1 stabilization, Serine228 autophosphorylation and activation in cells, Open Biol, 12, 210264, 10.1098/rsob.210264 · DOI · Paper page
  39. 2023, TIM23 facilitates PINK1 activation by safeguarding against OMA1-mediated degradation in damaged mitochondria, Cell Rep, 42, 112454, 10.1016/j.celrep.2023.112454 · DOI
  40. 1995, Acidic receptor domains on both sides of the outer membrane mediate translocation of precursor proteins into yeast mitochondria, EMBO J, 14, 6318, 10.1002/j.1460-2075.1995.tb00322.x · DOI
  41. 10.1128/MCB.17.11.6574 · DOI
  42. 10.1074/jbc.272.30.18725 · DOI
  43. 10.1093/emboj/17.14.3886 · DOI
  44. 10.1073/pnas.96.7.3634 · DOI
  45. 10.1016/0003-2697(91)90094-A · DOI
  46. N.-V. Mohamed , et al., Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy. Brain Commun. 3, fcab223 (2021). · DOI
  47. 2022, Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editing, Stem Cell Res, 62, 102806, 10.1016/j.scr.2022.102806 · DOI
  48. 10.4161/auto.26122 · DOI · Paper page
  49. 10.1093/emboj/cdf445 · DOI · Paper page
  50. M. U. Stevens , et al., Structure-based design and characterization of Parkin activating mutations. 2022.02.22.481412 (2022). · DOI
  51. 10.1371/journal.pone.0058435 · DOI
  52. 2022, The role of the individual TOM subunits in the association of PINK1 with depolarized mitochondria, J. Mol. Med, 100, 747, 10.1007/s00109-022-02191-6 · DOI · Paper page
  53. M. Bhagawati , et al., The receptor subunit Tom20 is dynamically associated with the TOM complex in mitochondria of human cells. Mol. Biol. Cell 32, br1 (2021). · DOI
  54. 10.1073/pnas.2200158119 · DOI
  55. 2020, Atomic structure of human TOM core complex, Cell Discov, 6, 1
  56. 10.1002/emmm.200900024 · DOI · Paper page
  57. 10.1002/humu.9472 · DOI
  58. 10.1093/brain/awl005 · DOI
  59. 10.1007/s00415-008-0763-4 · DOI
  60. 2005, Exclusion of PINK1 as candidate gene for the late-onset form of Parkinson’s disease in two European populations, J. Negat. Results Biomed, 4, 10, 10.1186/1477-5751-4-10 · DOI
  61. 10.1093/nar/gkx1153 · DOI · Paper page
  62. 10.1074/jbc.RA118.006506 · DOI
  63. 10.1016/j.cell.2005.01.011 · DOI
  64. 10.1038/s41467-021-26016-1 · DOI
  65. S. I. Sim , Y. Chen , D. L. Lynch , J. C. Gumbart , E. Park , Structural basis of mitochondrial protein import by the TIM23 complex. Nature, 1–7 (2023). · DOI
  66. X. Zhou , et al., Molecular pathway of mitochondrial preprotein import through the TOM-TIM23 supercomplex. 2023.06.21.546012 (2023). · DOI · Paper page
  67. 10.1038/ncomms5129 · DOI
  68. 10.1038/s41594-019-0339-2 · DOI
  69. 10.1038/ncomms2016 · DOI
  70. 10.15252/embr.201744981 · DOI
  71. 10.1038/ncomms14697 · DOI
  72. 2021, A Multistep Workflow to Evaluate Newly Generated iPSCs and Their Ability to Generate Different Cell Types, Methods Protoc, 4, 50, 10.3390/mps4030050 · DOI
  73. 2022, Microfabricated disk technology: Rapid scale up in midbrain organoid generation, Methods San Diego Calif, 203, 465, 10.1016/j.ymeth.2021.07.008 · DOI
  74. 2019, The landscape of Parkin variants reveals pathogenic mechanisms and therapeutic targets in Parkinson’s disease, Hum. Mol. Genet, 28, 2811, 10.1093/hmg/ddz080 · DOI
  75. 10.1073/pnas.1901805116 · DOI
  76. 2008, Simultaneous inference in general parametric models, Biom. J. Biom. Z, 50, 346
  77. 10.1021/acs.jproteome.9b00496 · DOI
  78. 10.1038/nprot.2016.136 · DOI
  79. 2022, ColabFold: making protein folding accessible to all, Nat. Methods, 19, 679, 10.1038/s41592-022-01488-1 · DOI · Paper page
  80. 10.1002/pro.4379 · DOI · Paper page

Authors
Eldeeb, M. A., Bayne, A. N., Fallahi, A., Goiran, T., MacDougall, E. J., Soumbasis, A., Zorca, C. E., Tabah, J.-J., Thomas, R. A., Karpilovsky, N., Mathur, M., Durcan, T. M., Trempe, J.-F., & Fon, E. A.
Affiliations
  • Montreal Neurological Institute and Hospital (CA)
  • Structural Genomics Consortium (CA)
Corresponding author
  • Eldeeb, Mohamed A.
  • Bayne, Andrew N.
  • Trempe, Jean-François
  • Fon, Edward A.
Venue
Proceedings of the National Academy of Sciences
Publisher
openRxiv
Published
2023-08-07
Volume
121
Issue
10
Pages
e2313540121-e2313540121
ISSN
0027-8424 (ISSN-L)
OpenAlex
W4392242690
Cited by
77
References
1
Citations by year
2026: 27 · 2025: 38 · 2024: 11 · 2023: 1
FWCI
20.24
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Michael J. Fox Foundation for Parkinson's Research (#18293)
  • Parkinson Canada
  • Canadian Institutes of Health Research (15430_1, FDN - 154301, 186189_1)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
PINK1, Tom20, TOM complex, TIM23 complex, mitophagy, mitochondrial quality control, Parkinson's disease, mitochondrial stress, mitochondrial import machinery, Parkin, dopaminergic neurons, midbrain organoids, PINK1 mutations
MeSH terms
Mitochondrial Precursor Protein Import Complex Proteins, Carrier Proteins, Humans, Mitochondria, Phosphorylation, Protein Kinases, Ubiquitin, Ubiquitin-Protein Ligases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review